Analysis of HIF-1 inhibition by manassantin A and analogues with modified tetrahydrofuran configurations.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2009-07-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmcl.2009.04.071PMID 19423348PMCID PMC2709708
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nucleophilic addition of organozinc reagents to 2-sulfonyl cyclic ethers: stereoselective synthesis of manassantins A and B.

  2009cited by this paper
• Stereoselective synthesis and osteogenic activity of subglutinols A and B.

  2009cited by this paper
• The impact of O2 availability on human cancer

  2008cited by this paper
• In vivo bioluminescence imaging monitoring of hypoxia-inducible factor 1alpha, a promoter that protects cells, in response to chemotherapy.

  2008cited by this paper
• Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth

  2008cited by this paper
• Turn me on: regulating HIF transcriptional activity

  2008cited by this paper
• A chemical genomics screen highlights the essential role of mitochondria in HIF-1 regulation

  2008cited by this paper
• Regulation of HIF-1α Stability through S-nitrosylation

  2007cited by this paper
• Regulation of HIF-1alpha stability through S-nitrosylation.

  2007cited by this paper
• Stereoselective synthesis of tetrahydrofuran lignans via BF(3) x OEt(2)-promoted reductive deoxygenation/epimerization of cyclic hemiketal: synthesis of (-)-odoratisol C, (-)-futokadsurin A, (-)-veraguensin, (+)-fragransin A(2), (+)-galbelgin, and (+)-talaumidin.

  2007cited by this paper
• Evaluation of HIF-1 inhibitors as anticancer agents.

  2007cited by this paper
• Hypoxia-Inducible Factor-1α Promotes Nonhypoxia-Mediated Proliferation in Colon Cancer Cells and Xenografts

  2006cited by this paper
• Hypoxia-Inducible Factor-1 (HIF-1)

  2006cited by this paper
• Saururus cernuus lignans--potent small molecule inhibitors of hypoxia-inducible factor-1.

  2005cited by this paper
• Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity.

  2005cited by this paper
• A manganese porphyrin superoxide dismutase mimetic enhances tumor radioresponsiveness.

  2005cited by this paper
• Molecular-targeted antitumor agents: the Saururus cernuus dineolignans manassantin B and 4-O-demethylmanassantin B are potent inhibitors of hypoxia-activated HIF-1.

  2004cited by this paper
• Small Molecule-Mediated Anti-Cancer Therapy via Hypoxia Inducible Factor-1 Blockade

  2004cited by this paper
• Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules.

  2004cited by this paper
• Enhancement of Hypoxia-Induced Tumor Cell Death In vitro and Radiation Therapy In vivo by Use of Small Interfering RNA Targeted to Hypoxia-Inducible Factor-1α

  2004cited by this paper
• Tumor microenvironmental physiology and its implications for radiation oncology.

  2004cited by this paper
• Targeting HIF-1 for cancer therapy

  2003cited by this paper
• HIF-1 as a target for drug development

  2003cited by this paper
• Inhibition of angiogenesis by NSAIDs: molecular mechanisms and clinical implications

  2003cited by this paper
• Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer.

  2002cited by this paper
• Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer.

  2001cited by this paper
• Suppression of tumor growth through disruption of hypoxia-inducible transcription

  2000cited by this paper
• Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck.

  1997cited by this paper
• Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix.

  1996cited by this paper
• Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.

  1995cited by this paper
• Density-functional thermochemistry. III. The role of exact exchange

  1993cited by this paper
• Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction.

  1993cited by this paper
• Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density.

  1988cited by this paper
• Density-functional exchange-energy approximation with correct asymptotic behavior.

  1988cited by this paper
• Manassantins A/B and saucerneol: novel biologically active lignoids from saururus cernuus

  1983cited by this paper
• Accurate spin-dependent electron liquid correlation energies for local spin density calculations: a critical analysis

  1980cited by this paper

• Novel anticancer drug discovery strategies targeting hypoxia-inducible factors

  2024cites this paper
• Action Sites and Clinical Application of HIF-1α Inhibitors

  2022cites this paper
• HIF‑1α: Its notable role in the maintenance of oxygen, bone and iron homeostasis (Review).

  2022cites this paper
• Synthesis and evaluation of 3-(phenylethynyl)-1,1'-biphenyl-2-carboxylate derivatives as new HIF-1 inhibitors.

  2021cites this paper
• Proteomics-based target identification of natural products affecting cancer metabolism

  2021cites this paper
• Hypoxia- and dexamethasone-dependent HIF1α-glucocorticoid receptor interaction leads to degradation of glucocorticoid receptor in pituitary adenomas.

  2021cites this paper
• Evaluation of Manassantin A Tetrahydrofuran Core Region Analogues and Cooperative Therapeutic Effects with EGFR Inhibition.

  2020cites this paper
• Structure-activity relationships study of neolamellarin A and its analogues as hypoxia inducible factor-1 (HIF-1) inhibitors.

  2019cites this paper
• Hypoxia‐inducible factor‐1 (HIF‐1) inhibitors from the last decade (2007 to 2016): A “structure–activity relationship” perspective

  2018cites this paper
• LXY6090 – a novel manassantin A derivative – limits breast cancer growth through hypoxia-inducible factor-1 inhibition

  2016cites this paper
• Discovery of Manassantin A Protein Targets Using Large-Scale Protein Folding and Stability Measurements.

  2016cites this paper
• Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2011-2015)

  2016cites this paper
• Synthesis and Biological Evaluation of Manassantin Analogues for Hypoxia-Inducible Factor 1α Inhibition

  2015cites this paper
• X609, a novel manassantin A derivative, exhibits antitumor activity in MG-63 human osteosarcoma cells in vitro and in vivo.

  2015cites this paper
• Evaluation of Energetics-based Techniques for Proteome-Wide Studies of Protein-Ligand Binding Interactions

  2015cites this paper
• A Synthetic Manassantin A Derivative Inhibits Hypoxia-Inducible Factor 1 and Tumor Growth

  2014cites this paper
• False-Positive Rate Determination of Protein Target Discovery using a Covalent Modification- and Mass Spectrometry-Based Proteomics Platform

  2013cites this paper
• HIFs, angiogenesis, and cancer

  2013cites this paper
• Substance de saucernétine de structure simplifiée et son procédé de préparation et sa composition pharmaceutique et son utilisation

  2012cites this paper
• Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.

  2012cites this paper
• Small-molecule inhibitors of dimeric transcription factors: Antagonism of protein–protein and protein–DNA interactions

  2012cites this paper
• The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness.

  2012cites this paper
• Synthesis and evaluation of quinazolin-4-ones as hypoxia-inducible factor-1α inhibitors.

  2011cites this paper
• Natural Products as Inhibitors of Hypoxia-Inducible Factor-1

  2011cites this paper
• I. Studies Towards the Synthesis of Manassantins A and B and Analogues II. Efforts Towards a FRET-Based Assay to Characterize Palmitoylation of Src Kinases III. Synthesis of Oxepanes via Organocatalytic Oxa-Michael Reactions

  2010cites this paper
• The role of hypoxia-inducible factor-1 in hyperthermia-induced tumor reoxygenation and therapy resistance

  2010cites this paper
• The hypoxic response and aging.

  2009cites this paper
• In vivo bioluminescence imaging monitoring of hypoxia-inducible factor 1alpha, a promoter that protects cells, in response to chemotherapy.

  2008cites this paper
• Duke University Dissertation Template

  2007cites this paper
• X 609 , a novel manassantin A derivative , exhibits antitumor activity in MG-63 human osteosarcoma cells in vitro and in vivo

  year unknowncites this paper